 Forskolin intermediate trophoblast phenotype cultured human choriocarcinoma cells human placenta membranes vital maintenance nutrition protection fetus placental development cytotrophoblasts rise chorionic membrane others differentiated syncytium cells responsible placental protein steroid hormone production mechanisms differentiation trophoblasts unknown intermediate stage characteristic phenotype vivo dissimilar xenobiotic agents BeWo choriocarcinoma cells usual cytotrophoblastic phenotype morphologic functional characteristics typical intermediate trophoblast Incubation BeWo cell cultures presence mumol/L methotrexate hours human chorionic gonadotropin secretion aromatase activity Morphologic findings hormonal changes nuclear size cytoplasmic expansion use computer-interfaced image analyzer planimetric morphometry nuclear area cells increase incubation methotrexate effect forskolin direct activator adenylyl cyclase means model cytotrophoblast differentiation addition mumol/L forskolin BeWo cultures dramatic changes trophoblast cell phenotype human chorionic gonadotropin synthesis aromatase activity nuclear area untreated cells addition increases thymidine incorporation treatments results biochemical cytologic changes human trophoblast differentiation vitro activation adenylyl cyclase pathway forskolin unknown independent signals methotrexate